CymaBay Therapeutics, Inc. announced the appointment of Dr. Éric Lefebvre to its Board of Directors. Dr. Lefebvre is serving as Chief Medical Officer of Pliant Therapeutics, Inc., a biopharmaceutical company, where he has served as such since May 2018. Prior to joining Pliant, Dr. Lefebvre served as the Vice President of Research and Development at Allergan plc, a global pharmaceutical company, from November 2016 until April 2018.
CymaBay Therapeutics, Inc.
Equities
CBAY
US23257D1037
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+10.63% | 115B | |
+12.10% | 106B | |
-5.51% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.49% | 17.56B | |
-40.50% | 17.32B | |
+6.36% | 14.03B | |
+30.48% | 12.13B |